![Reinhard Gabathuler](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Reinhard Gabathuler
Nessuna posizione attualmente
Storia della carriera di Reinhard Gabathuler
Precedenti posizioni note di Reinhard Gabathuler
Società | Posizione | Inizio | Fine |
---|---|---|---|
NEVIS BRANDS INC. | Direttore/Membro del Consiglio | 08/12/2015 | 16/07/2018 |
Amministratore Delegato | 28/05/2013 | 08/12/2015 | |
Corporate Officer/Principal | 28/05/2013 | 16/07/2018 | |
Presidente | 28/05/2013 | 08/12/2015 | |
BIOASIS TECHNOLOGIES INC. | Direttore Tecnico/Scientifico/R&S | - | 18/09/2017 |
Ludwig Institute for Cancer Research Ltd.
![]() Ludwig Institute for Cancer Research Ltd. Medical/Nursing ServicesHealth Services Ludwig Institute For Cancer Research Ltd. is non-profit organization engages in the prevention and control of cancer through researches, integrated laboratory and clinical trials. The firm operates in the areas of cell biology, genomics, immunology, neuroscience, signaling, stem cells, therapeutic, tumor biology, brain and breast cancer, immunotherapy, and melanoma. The company was founded by Daniel K. Ludwig in 1971 and is headquartered in New York, NY. | Corporate Officer/Principal | - | - |
University of British Columbia | Corporate Officer/Principal | - | - |
Synapse Technologies, Inc.
![]() Synapse Technologies, Inc. Pharmaceuticals: MajorHealth Technology Synapse Technologies Inc. develops an Alzheimer's diagnostic test and potential blood/brain drug delivery mechanism based on the p97 protein. | Direttore Tecnico/Scientifico/R&S | - | - |
Fondatore | - | - | |
BIOMARIN PHARMACEUTICAL INC. | Direttore Tecnico/Scientifico/R&S | - | - |
Angiochem, Inc.
![]() Angiochem, Inc. Pharmaceuticals: MajorHealth Technology Angiochem, Inc. is a clinical-stage biotechnology company, which engages in the development of pharmaceutical drugs for brain diseases and brain-related disorders. It offers small molecules and biologics, for the treatment of central nervous system diseases including primary brain cancer, brain metastases, lysosomal storage diseases, and pain. The company founded by Richard Béliveau in 2003 and is headquartered in Montreal, Canada. | Direttore Tecnico/Scientifico/R&S | 01/01/2004 | - |
Formazione di Reinhard Gabathuler
University of Lausanne | Doctorate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 5 |
Canada | 4 |
Svizzera | 2 |
Posizioni
Chief Tech/Sci/R&D Officer | 4 |
Corporate Officer/Principal | 3 |
Doctorate Degree | 1 |
Settori
Health Technology | 6 |
Consumer Services | 3 |
Health Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 3 |
---|---|
BIOMARIN PHARMACEUTICAL INC. | Health Technology |
BIOASIS TECHNOLOGIES INC. | Health Technology |
NEVIS BRANDS INC. | Health Technology |
Aziende private | 3 |
---|---|
Synapse Technologies, Inc.
![]() Synapse Technologies, Inc. Pharmaceuticals: MajorHealth Technology Synapse Technologies Inc. develops an Alzheimer's diagnostic test and potential blood/brain drug delivery mechanism based on the p97 protein. | Health Technology |
Angiochem, Inc.
![]() Angiochem, Inc. Pharmaceuticals: MajorHealth Technology Angiochem, Inc. is a clinical-stage biotechnology company, which engages in the development of pharmaceutical drugs for brain diseases and brain-related disorders. It offers small molecules and biologics, for the treatment of central nervous system diseases including primary brain cancer, brain metastases, lysosomal storage diseases, and pain. The company founded by Richard Béliveau in 2003 and is headquartered in Montreal, Canada. | Health Technology |
Ludwig Institute for Cancer Research Ltd.
![]() Ludwig Institute for Cancer Research Ltd. Medical/Nursing ServicesHealth Services Ludwig Institute For Cancer Research Ltd. is non-profit organization engages in the prevention and control of cancer through researches, integrated laboratory and clinical trials. The firm operates in the areas of cell biology, genomics, immunology, neuroscience, signaling, stem cells, therapeutic, tumor biology, brain and breast cancer, immunotherapy, and melanoma. The company was founded by Daniel K. Ludwig in 1971 and is headquartered in New York, NY. | Health Services |
- Borsa valori
- Insiders
- Reinhard Gabathuler
- Esperienza